Literature DB >> 27245704

G534E Variant in HABP2 and Nonmedullary Thyroid Cancer.

Macarena Ruiz-Ferrer1,2, Raquel M Fernández1,2, Elena Navarro2,3, Guillermo Antiñolo1,2, Salud Borrego1,2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2016        PMID： 27245704      PMCID： PMC4939372          DOI： 10.1089/thy.2016.0193

Source DB:  PubMed          Journal:  Thyroid        ISSN： 1050-7256            Impact factor:   6.568


× No keyword cloud information.
  9 in total

1.  HABP2 Mutation and Nonmedullary Thyroid Cancer.

Authors:  Jerneja Tomsic; Huiling He; Albert de la Chapelle
Journal:  N Engl J Med       Date:  2015-11-19       Impact factor: 91.245

2.  HABP2 Mutation and Nonmedullary Thyroid Cancer.

Authors:  Marialuisa Sponziello; Cosimo Durante; Sebastiano Filetti
Journal:  N Engl J Med       Date:  2015-11-19       Impact factor: 91.245

3.  HABP2 Mutation and Nonmedullary Thyroid Cancer.

Authors:  Ximeng Zhao; Xiaoyi Li; Xue Zhang
Journal:  N Engl J Med       Date:  2015-11-19       Impact factor: 91.245

4.  HABP2 Mutation and Nonmedullary Thyroid Cancer.

Authors:  E Yihui Zhou; Zhimiao Lin; Yong Yang
Journal:  N Engl J Med       Date:  2015-11-19       Impact factor: 91.245

5.  HABP2 Gene Mutations Do Not Cause Familial or Sporadic Non-Medullary Thyroid Cancer in a Highly Inbred Middle Eastern Population.

Authors:  Ali S Alzahrani; Avaniyapuram Kannan Murugan; Ebtesam Qasem; Hindi Al-Hindi
Journal:  Thyroid       Date:  2016-04-08       Impact factor: 6.568

6.  Germline HABP2 Mutation Causing Familial Nonmedullary Thyroid Cancer.

Authors:  Sudheer Kumar Gara; Li Jia; Maria J Merino; Sunita K Agarwal; Lisa Zhang; Maggie Cam; Dhaval Patel; Electron Kebebew
Journal:  N Engl J Med       Date:  2015-07-30       Impact factor: 91.245

7.  The HABP2 G534E variant is an unlikely cause of familial non-medullary thyroid cancer.

Authors:  Ruta Sahasrabudhe; Jacob Stultz; John Williamson; Paul Lott; Ana Estrada; Mabel Bohorquez; Claire Palles; Guadalupe Polanco-Echeverry; Emma Jaeger; Lynn Martin; Maria Magdalena Echeverry; Ian Tomlinson; Luis G Carvajal-Carmona
Journal:  J Clin Endocrinol Metab       Date:  2015-12-21       Impact factor: 5.958

8.  267 Spanish Exomes Reveal Population-Specific Differences in Disease-Related Genetic Variation.

Authors:  Joaquín Dopazo; Alicia Amadoz; Marta Bleda; Luz Garcia-Alonso; Alejandro Alemán; Francisco García-García; Juan A Rodriguez; Josephine T Daub; Gerard Muntané; Antonio Rueda; Alicia Vela-Boza; Francisco J López-Domingo; Javier P Florido; Pablo Arce; Macarena Ruiz-Ferrer; Cristina Méndez-Vidal; Todd E Arnold; Olivia Spleiss; Miguel Alvarez-Tejado; Arcadi Navarro; Shomi S Bhattacharya; Salud Borrego; Javier Santoyo-López; Guillermo Antiñolo
Journal:  Mol Biol Evol       Date:  2016-01-13       Impact factor: 16.240

9.  HABP2 G534E Variant in Papillary Thyroid Carcinoma.

Authors:  Jerneja Tomsic; Rebecca Fultz; Sandya Liyanarachchi; Huiling He; Leigha Senter; Albert de la Chapelle
Journal:  PLoS One       Date:  2016-01-08       Impact factor: 3.240
  9 in total
  9 in total

1.  Next Generation Sequencing and Association Studies in Familial Nonmedullary Thyroid Carcinoma: Let's Choose Appropriate Controls.

Authors:  Laure Cazabat; Aglae Terray; Philippe de Mazancourt; Jacques Ropers; Lionel Groussin; Marie-Laure Raffin-Sanson
Journal:  Eur Thyroid J       Date:  2017-06-23

2.  Targeted next-generation sequencing in papillary thyroid carcinoma patients looking for germline variants predisposing to the disease.

Authors:  Chen-Tian Shen; Guo-Qiang Zhang; Zhong-Ling Qiu; Hong-Jun Song; Zhen-Kui Sun; Quan-Yong Luo
Journal:  Endocrine       Date:  2019-03-02       Impact factor: 3.633

3.  The p.G534E variant of HABP2 is not associated with sporadic papillary thyroid carcinoma in a Polish population.

Authors:  Artur Kowalik; Danuta Gąsior-Perczak; Martyna Gromek; Monika Siołek; Agnieszka Walczyk; Iwona Pałyga; Małgorzata Chłopek; Janusz Kopczyński; Ryszard Mężyk; Aldona Kowalska; Stanisław Góźdź
Journal:  Oncotarget       Date:  2017-04-06

4.  HABP2 p.G534E variant in patients with family history of thyroid and breast cancer.

Authors:  Maisa Pinheiro; Sandra Aparecida Drigo; Renata Tonhosolo; Sonia C S Andrade; Fabio Albuquerque Marchi; Igor Jurisica; Luiz Paulo Kowalski; Maria Isabel Achatz; Silvia Regina Rogatto
Journal:  Oncotarget       Date:  2017-06-20

5.  Clinical and Genetic Features of a Large Monocentric Series of Familial Non-Medullary Thyroid Cancers.

Authors:  Valentina Cirello; Carla Colombo; Olga Karapanou; Gabriele Pogliaghi; Luca Persani; Laura Fugazzola
Journal:  Front Endocrinol (Lausanne)       Date:  2021-01-07       Impact factor: 5.555

Review 6.  Inherited Follicular Epithelial-Derived Thyroid Carcinomas: From Molecular Biology to Histological Correlates.

Authors:  José Manuel Cameselle-Teijeiro; Ozgur Mete; Sylvia L Asa; Virginia LiVolsi
Journal:  Endocr Pathol       Date:  2021-01-25       Impact factor: 3.943

Review 7.  Susceptibility Genes and Chromosomal Regions Associated With Non-Syndromic Familial Non-Medullary Thyroid Carcinoma: Some Pathogenetic and Diagnostic Keys.

Authors:  María Sánchez-Ares; Soledad Cameselle-García; Ihab Abdulkader-Nallib; Gemma Rodríguez-Carnero; Carolina Beiras-Sarasquete; José Antonio Puñal-Rodríguez; José Manuel Cameselle-Teijeiro
Journal:  Front Endocrinol (Lausanne)       Date:  2022-02-28       Impact factor: 5.555

8.  Pitfalls of exome sequencing: a case study of the attribution of HABP2 rs7080536 in familial non-medullary thyroid cancer.

Authors:  Glenn S Gerhard; Darrin V Bann; James Broach; David Goldenberg
Journal:  NPJ Genom Med       Date:  2017-03-28       Impact factor: 8.617

Review 9.  Influencers on Thyroid Cancer Onset: Molecular Genetic Basis.

Authors:  Berta Luzón-Toro; Raquel María Fernández; Leticia Villalba-Benito; Ana Torroglosa; Guillermo Antiñolo; Salud Borrego
Journal:  Genes (Basel)       Date:  2019-11-08       Impact factor: 4.096
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.